China NT Pharma Group Co., Ltd. ( (HK:1011) ) has provided an announcement.
China NT Pharma Group Co., Ltd. has announced that its board of directors will convene on March 31, 2025, to approve the release of the company’s final results for the year ending December 31, 2024. This meeting is significant as it will provide insights into the company’s financial performance and could impact its market positioning and stakeholder interests.
More about China NT Pharma Group Co., Ltd.
China NT Pharma Group Co., Ltd. operates within the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company primarily serves markets in China and is engaged in providing a range of healthcare solutions.
YTD Price Performance: -12.96%
Average Trading Volume: 139,047
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: HK$158.4M
For a thorough assessment of 1011 stock, go to TipRanks’ Stock Analysis page.